| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 548.57 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 641.801 | 93 |
| GSM780709 | Untreated after 4 days (C3_1) | 461.683 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 605.684 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 774.167 | 94 |
| GSM780721 | Untreated after 4 days (C3_2) | 486.405 | 91 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 675.947 | 94 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 598.413 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 688.35 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 654.607 | 93 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 648.058 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 721.874 | 94 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 448.936 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 624.233 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 537.007 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 509.862 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 597.503 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 546.534 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 766.208 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 651.57 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 678.281 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 721.085 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 653.924 | 93 |